Role and significance of multiparametric magnetic resonance imaging in prostate cancer diagnostics

Cover Page

Cite item

Full Text

Abstract

The problem of timely diagnosis and malignancy grade evaluation of prostate cancer is especially urgent considering continuous and progredient increase in morbidity and mortality caused by this nosology, as well as difficulty of diagnostics. The conducted literature review shows that currently magnetic resonance imaging (MRI) is the leading method for diagnostics and grading of primary prostate cancer, as well as evaluation of local metastases, diagnostics of distant metastases, and identification of recurrences in the prostatic fossa after radical prostatectomy. Sensitivity and specificity of MRI are higher than in any of the other safe methods of diagnostic radiology. Active and wide-scale introduction of MRI into routine urological practice provided an impetus for development of complementary modalities and methods including fusion biopsy, targeted prostate biopsy under control of MRI, active observation, focal therapy, and other methods, significance and effectiveness of which will be determined in the future. 

About the authors

Ph. A. Kossov

Russian Medical Academy of Continuous Professional Education

Author for correspondence.
Email: fil-doc@yandex.ru
Build. 1, 2/1 Barrikadnaya St., Moscow 125993 Russian Federation

V. A. Chernyaev

N.N. Blokhin Russian Cancer Research Center

Email: Chercrc@gmail.com
Build. 1, 2/1 Barrikadnaya St., Moscow 125993 Russian Federation

G. I. Akhverdieva

N.N. Blokhin Russian Cancer Research Center

Email: Chercrc@gmail.com
Russian Federation

B. Sh. Kamolov

European Medical Center

Email: kamolov@mail.ru
35 Shchepkina St., Moscow 129090 Russian Federation

I. I. Abdullin

European Medical Center

35 Shchepkina St., Moscow 129090 Russian Federation

V. O. Panov

Russian Medical Academy of Continuous Professional Education;
N.N. Blokhin Russian Cancer Research Center

Yu. V. Buydenok

N.N. Blokhin Russian Cancer Research Center

Russian Federation

V. B. Matveev

N.N. Blokhin Russian Cancer Research Center

Russian Federation

I. E. Turin

Russian Medical Academy of Continuous Professional Education

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36986 от  21.07.2009.